We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMCI icon
526
Super Micro Computer
SMCI
$16.6B
$1.44M 0.01%
29,972
+1,196
+4% +$57.1K
CNI icon
527
Canadian National Railway
CNI
$78.5B
$1.43M 0.01%
15,158
-1,468
-9% -$142K
IP icon
528
International Paper
IP
$22.6B
$1.4M 0.01%
30,153
-1,404
-4% -$68.6K
ZM icon
529
Zoom
ZM
$27.1B
$1.4M 0.01%
16,926
+366
+2% +$28.6K
PFG icon
530
Principal Financial Group
PFG
$24.3B
$1.39M 0.01%
16,781
-2,247
-12% -$180K
WAT icon
531
Waters Corp
WAT
$37.3B
$1.36M 0.01%
4,548
-1,146
-20% -$346K
WST icon
532
West Pharmaceutical
WST
$23.7B
$1.32M 0.01%
5,030
-740
-13% -$180K
EG icon
533
Everest Group
EG
$15.6B
$1.31M 0.01%
3,751
NTNX icon
534
Nutanix
NTNX
$16.1B
$1.29M 0.01%
17,356
-3,675
-17% -$270K
ATAT icon
535
Atour Lifestyle Holdings
ATAT
$4.81B
$1.27M 0.01%
+33,800
New +$1.24M
JBHT icon
536
JB Hunt Transport Services
JBHT
$25.9B
$1.26M 0.01%
9,392
-561
-6% -$80.7K
TTD icon
537
Trade Desk
TTD
$8.97B
$1.25M 0.01%
25,571
ESS icon
538
Essex Property Trust
ESS
$19.1B
$1.23M 0.01%
4,579
-41
-0.9% -$11.1K
PINS icon
539
Pinterest
PINS
$13.7B
$1.22M 0.01%
37,865
-11,301
-23% -$410K
MCHP icon
540
Microchip Technology
MCHP
$38.8B
$1.22M 0.01%
18,942
-1,772
-9% -$120K
LVS icon
541
Las Vegas Sands
LVS
$32.2B
$1.21M 0.01%
22,572
-7,331
-25% -$385K
HHH icon
542
Howard Hughes
HHH
$3.94B
$1.21M 0.01%
14,757
-137,189
-90% -$10.2M
WY icon
543
Weyerhaeuser
WY
$17.6B
$1.21M 0.01%
48,802
P
544
Everpure Inc
P
$23B
$1.21M 0.01%
14,393
-1,078
-7% -$71.7K
DRI icon
545
Darden Restaurants
DRI
$24.3B
$1.2M 0.01%
6,314
-76
-1% -$15.6K
ZBH icon
546
Zimmer Biomet
ZBH
$18.8B
$1.19M 0.01%
12,093
-1,209
-9% -$120K
BBY icon
547
Best Buy
BBY
$19B
$1.19M 0.01%
15,677
+1,946
+14% +$140K
BNS icon
548
Scotiabank
BNS
$105B
$1.17M 0.01%
18,021
-4,241
-19% -$250K
CHD icon
549
Church & Dwight Co
CHD
$23.7B
$1.14M 0.01%
13,047
-133
-1% -$12.5K
SUI icon
550
Sun Communities
SUI
$15.8B
$1.12M 0.01%
8,711
-123,079
-93% -$15.6M

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.